Squarepoint
BNTX icon

Squarepoint’s BioNTech BNTX Stock Holding History

Squarepoint’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
12,900
+8,400
+187% +$863K ﹤0.01% 2659
2025
Q4 		$428K Sell
4,500
-2,600
-37% -$262K ﹤0.01% 3334
2025
Q3 		$700K Buy
+7,100
New +$759K ﹤0.01% 2950
2025
Q1 		– Sell
-35,900
Closed -$4.09M – 4615
2024
Q4 		$4.09M Buy
35,900
+19,200
+115% +$2.19M ﹤0.01% 1804
2024
Q3 		$1.98M Buy
+16,700
New +$1.54M ﹤0.01% 2079
2024
Q2 		– Sell
-26,900
Closed -$2.48M – 4074
2024
Q1 		$2.48M Buy
26,900
+2,700
+11% +$259K ﹤0.01% 1949
2023
Q4 		$2.55M Buy
24,200
+2,500
+12% +$252K ﹤0.01% 1844
2023
Q3 		$2.36M Sell
21,700
-10,400
-32% -$1.15M 0.01% 1686
2023
Q2 		$3.46M Buy
32,100
+27,400
+583% +$3.08M 0.01% 1303
2023
Q1 		$585K Buy
+4,700
New +$645K ﹤0.01% 2215

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Squarepoint's BNTX Position: Q1 2026 in Review

Squarepoint increased its BioNTech (BNTX) stake by 146% in Q1 2026, buying an estimated $5.05M and bringing the position to 82,849 shares worth $7.36M. The position accounts for 0.01% of the portfolio, ranked #1248.

Squarepoint first reported a position in BNTX in Q2 2020 and has held it in 22 quarters since. The position peaked at $42.1M in Q4 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Squarepoint held 82,849 shares of BioNTech worth $7.36M as of Q1 2026.
  • Squarepoint bought 49,105 BioNTech shares in Q1 2026, an estimated $5.05M.
  • BioNTech made up 0.01% of Squarepoint's portfolio in Q1 2026, its #1248 holding.
  • Squarepoint first reported a position in BioNTech in Q2 2020 and has held it in 22 quarters since.
  • Squarepoint's BioNTech position peaked at $42.1M in Q4 2024.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.